Carregant...
Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
Breast cancer (BC) is still the most common cancer among women worldwide. Amongst the subtypes of BC, triple negative breast cancer (TNBC) is characterized by deficient expression of estrogen, progesterone, and human epidermal growth factor receptor 2 receptors. These patients are therefore not give...
Guardat en:
| Publicat a: | J Breast Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean Breast Cancer Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769384/ https://ncbi.nlm.nih.gov/pubmed/31598336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2019.22.e39 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|